Mini-Symposium 1
Preoperative chemoradiotherapy for pancreatic surgery

[MSY1-4] A prospective, open-label, multicenter phase II trial of neoadjuvant therapy using full-dose of gemcitabine and S-1 concurrent with radiation for resectable pancreatic adenocarcinoma

^○Yutaka Takeda^1,5, Hidetoshi Eguchi^2,5, Hidenori Takahashi⁵, Shin Nakahira⁵, Masaki Kashiwazaki⁵, Junzo Shimizu⁵, Yoshiaki Ohmura^1,5, Yoshiteru Katsura^1,5, Hiroaki Nagano^3,5, Daisuke Sakai⁵, Fumiaki Isohashi^4,5, Masaki Mori^2,5, Yuichiro Doki^2,5 (1.Department of Surgery, Kansai Rosai Hospital, 2.Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 3.Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, 4.Department of Radiation Oncology, Graduate School of Medicine, Osaka University, 5.Clinical Study Group of Osaka University, Hepato-Biliary-Pancreatic Group)